REBECCA NIELSEN: Open Payments
NPI 1548595838 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 39 payments from 14 companies in 2025. Trend: 2023 $510 · 2024 $248 · 2025 $1,116
Food & beverage: $1,116
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $308 |
| AstraZeneca Pharmaceuticals LP | 4 | $170 |
| Novo Nordisk Inc | 5 | $133 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| ViiV Healthcare Company | 3 | $86 |
| PFIZER INC. | 3 | $73 |
| Exact Sciences Corporation | 3 | $63 |
| ABBVIE INC. | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Hologic Sales and Service, LLC | 1 | $23 |
Products named: OTEZLA, REPATHA, AIRSUPRA, REXULTI, APRETUDE, NURTEC ODT, VRAYLAR, NEXIUM.
Industry payments across CO — which companies pay providers there.
